Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Isabelle Arnet; Melina Verbeek; Birna Almarsdóttir Anna; Liese Barbier; Rhonda Clifford; Christiane Eickhoff; Kurt Hersberger; Isabelle Huys; Kenny Lee; Kritsanee Saramunee; Martin Schulz; David Zgarrick; Kati Sarnola

Exploratory Research in Clinical and Social Pharmacy (Dec 2021)

Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

Isabelle Arnet,
Melina Verbeek,
Birna Almarsdóttir Anna,
Liese Barbier,
Rhonda Clifford,
Christiane Eickhoff,
Kurt Hersberger,
Isabelle Huys,
Kenny Lee,
Kritsanee Saramunee,
Martin Schulz,
David Zgarrick,
Kati Sarnola

Affiliations

Isabelle Arnet: Pharmaceutical Care Research Group, University of Basel, Petersplatz 14, P.O. Box 4128 4001, Basel, Switzerland; Corresponding author.
Melina Verbeek: Pharmaceutical Care Research Group, University of Basel, Petersplatz 14, P.O. Box 4128 4001, Basel, Switzerland
Birna Almarsdóttir Anna: University of Copenhagen, Faculty of Health and Medical Sciences, Department of Pharmacy, Social and Clinical Pharmacy, Universitetsparken 2, 2100 Copenhagen, Denmark
Liese Barbier: KU Leuven, Clinical Pharmacology and Pharmacotherapy, O&N II Herestraat 49, box 521, 3000 Leuven, Belgium
Rhonda Clifford: School of Allied Health, The University of Western Australia, 35 Stirling Highway, Crawlex WA 6009, Australia
Christiane Eickhoff: Department of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Heidestr. 7, 10557 Berlin, Germany
Kurt Hersberger: Pharmaceutical Care Research Group, University of Basel, Petersplatz 14, P.O. Box 4128 4001, Basel, Switzerland
Isabelle Huys: KU Leuven, Clinical Pharmacology and Pharmacotherapy, O&N II Herestraat 49, box 521, 3000 Leuven, Belgium
Kenny Lee: School of Allied Health, The University of Western Australia, 35 Stirling Highway, Crawlex WA 6009, Australia
Kritsanee Saramunee: Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, 44150, Thailand
Martin Schulz: Department of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Heidestr. 7, 10557 Berlin, Germany
David Zgarrick: Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA
Kati Sarnola: The Social Insurance Institution of Finland (Kela), Research at Kela, P.O. Box 450, 00056 Kela, Finland

Journal volume & issue: Vol. 4
p. 100084

Abstract

Read online

Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.

Published in Exploratory Research in Clinical and Social Pharmacy

ISSN: 2667-2766 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Pharmacy and materia medica
Website: https://www.journals.elsevier.com/exploratory-research-in-clinical-and-social-pharmacy

About the journal

Abstract

Keywords